Taiwan Arms Sale Approved by Congress Is Delayed as Trump Plans Visit to Beijing
Why it matters: This situation underscores the precarious nature of U.S. foreign policy under Trump, where strategic alliances and Congressional mandates can be sidelined for perceived short-term diplomatic gains, potentially emboldening adversaries and undermining U.S. credibility.
- The State Department is stalling the arms sale to Taiwan, despite Congressional approval.
- The Trump Administration is prioritizing a summit with China, potentially at the expense of commitments to Taiwan.
- Congress is simultaneously engaged in a broader debate over war powers, intensified by Trump's unilateral actions in Iran (per AP), suggesting growing friction between the executive and legislative branches on foreign policy.
A multi-billion dollar arms sale to Taiwan, already approved by Congress, is being held up by the State Department, likely to avoid upsetting China ahead of a planned summit between Trump and Chinese leaders. This delay highlights the tension between supporting Taiwan's defense and maintaining stable relations with Beijing, a delicate balancing act with global implications.
